Ingenza is redefining drug substance development with its inGenius® platform

We deliver scalable, efficient and ICH-compliant bioprocesses for our customer IND applications. Built on decades of experience, our inGenius® platform has been developed with a focus on improving efficiency and de-risking future processes by enhancing four key modules: Strain/Cell-line Development; Process Development; Analytical Development and Manufacture of pre-clinical material.

Our platform is modality-agnostic and has successfully been applied to the recombinant expression of complex proteins, peptides, monoclonal and VHH antibodies, enzymes and subunit vaccines.

You can read more about these components below.

Our biologics-based pharmaceutical technology modules

Strain / cell-line development module

Optimal gene design and appropriate mammalian, yeast or bacterial production host selected for individual biologic target. Gene expression and strain/cell-line stability optimised. Initial product characterisation. Research cell banks prepared.

Process development module

Cost-competitive, scalable ​and robust bioprocesses. Process design for biologics preparation to customer specification with over 70 parameters monitored and optimised (upstream & downstream).

Analytical development module

Full analytical (bio)chemistry suite supporting final product, purity, identity and potency characterisation, in process analysis and release testing. Documentation, materials and processes controlled through QMS, ensuring traceability and full regulatory compliance.

Non-GMP Manufacture module

Material for pre-clinical, pre-formulation and stability testing using optimised hosts and individually tailored manufacturing process.

Success stories

Examples of the tailored support that accelerates our customers along the path to commercial success.

Each stage of client product and process development delivered through a uniquely integrated portfolio of bio-manufacturing technologies.

Superior enzyme productivity and purity

Read

Efficient manufacture of first-in-class antimicrobial

Read

Your project